On May 4, Charles River Laboratories International reveals figures for Q1.
16 analysts are forecasting earnings of $2.19 per share compared to earnings of $1.84 per share in the same quarter of the previous year.
Estimates from analysts predict sales for the quarter to come in at $795.7 million. That would represent an increase of 12.54% compared to the prior year quarter.
For the current fiscal year analysts expect a profit per share of $9.24, whereas in the previous year $8.13 had been reported. On the revenue side analysts estimate that the company will bring in $3.38 billion in the current fiscal year.
This story was written by Markets Insider’s RoboEddy, which automatically writes these stories based on data provided by our partners.